STAAR Surgical Company Stock 12‑Month Price Target Raised to $30.5, Implies 6% Upside

Analysts have raised the average 12-month price target for STAAR Surgical Company to $30.5, implying a 6% upside from the June 11 closing price. The consensus rating among 11 covering analysts has shifted to 'Buy', comprising 3 Buys and 8 Holds. Price forecasts range from $25 to $40 per share.

According to estimates from 8 analysts, STAAR Surgical Company stock's average price target has risen from $29.67 to $30.5, with forecasts ranging from $25 to $40 per share
Based on the Jun. 11 closing price, the updated target implies approximately 6% potential upside
Consensus rating has shifted to “Buy” across 11 covering analysts, with 3 Buys, 8 Holds and 0 Sells

Explore more price target data and ratings for STAAR Surgical Company on the , and track all previous and future analyst recommendations for STAAR Surgical Company in the dedicated News Flow.

Disclaimer

Select reference data provided by FactSet. Copyright © 2026 FactSet Research Systems Inc. This information is not a recommendation for what you should do personally and does not constitute investment advice.